Regn stockholders have opportunity to lead regeneron therapeutics, inc. class action lawsuit – contact bronstein, gewirtz and grossman, llc today!

New york city, ny / access newswire / january 27, 2025 / bronstein, gewirtz & grossman, llc, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or "the company") (nasdaq:regn) and certain of its officers. class definition this lawsuit seeks to recover damages against defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired regeneron securities between november 2, 2023 and october 30, 2024, both dates inclusive (the "class period").
REGN Ratings Summary
REGN Quant Ranking